PetMed Express appoints James LaCamp to board of directors

PetMed Express (PETS) announced the appointment, effective immediately, of James LaCamp to the Company’s Board of Directors, and effective October 30, Mr. LaCamp will become Chair of the Audit Committee of the Board. Mr. LaCamp also qualifies as an “audit committee financial expert” within the meaning of the SEC’s rules and regulations. Currently, Mr. LaCamp serves as the CFO of Skydio. The Board has determined that Mr. LaCamp qualifies as an “independent director” as defined under Rule 5605(a)(2) of the Nasdaq Marketplace Rules. In addition to being named as Chair of the Audit Committee effective October 30, 2025, concurrently with being named to the Board effective immediately, Mr. LaCamp has also been appointed as a member of the Board’s Audit Committee and of the Compensation and Human Capital Committee.